Intrathecal Tetanus Immunoglobulin to Treat Tetanus
NCT02999815
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
272
Enrollment
OTHER
Sponsor class
Conditions
Tetanus
Interventions
PROCEDURE:
Human tetanus immunoglobulin
PROCEDURE:
Intramuscular antitoxin
Sponsor
Oxford University Clinical Research Unit, Vietnam
Collaborators
[object Object]